The Globe and Mail reports in its Thursday, Nov. 14, edition that TD Cowen analyst Brian Morrison has reaffirmed his "buy" recommendation for Martinrea International. The Globe's David Leeder writes that Mr. Morrison slashed his share target back by $5 to $13. Analysts on average target the shares at $16.63. Mr. Morrison says in a note: "We maintain our 'buy' rating, but acknowledge it is geared toward deep value investors, with upside to the shares likely pushed out relative to our prior outlook. Although mid-term upside remains material, in our view, it may fall into the 'value trap' categorization near term with a 'soft' Q4 outlook, moderating consumer demand and [North American] inventory in equilibrium, and uncertainty pertaining to tariffs." The Globe reported on Dec. 20 that CIBC World Markets analyst Krista Friesen had elevated her recommendation for Martinrea to "outperformer" from "neutral." It was then worth $13.78. The Globe reported on March 1 that Scotia Capital analyst Jonathan Goldman had lowered Martinrea to "sector perform" from "sector outperform." It was then worth $12.20. The Globe's guest columnist Robert Tattersall was keen on Martinrea on Aug. 29 when the shares were trading at $11.23.